Elicio Therapeutics Inc.
6.35
0.15 (2.42%)
At close: Jan 15, 2025, 3:43 PM
6.39
0.63%
After-hours Jan 15, 2025, 03:44 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY13 FY12
Revenue n/a n/a 28.31M 2.88M 1.49M 4.03M 6.58M 7.30M
Cost of Revenue 1.17M 1.06M 1.23M 1.82M 1.14M 380.00K 3.17M 3.67M
Gross Profit -1.17M -1.06M 27.08M 1.06M 351.00K 3.65M 3.41M 3.62M
Operating Income -35.74M -23.73M -25.47M -15.72M -12.34M -14.34M -397.80K -419.22K
Interest Income 373.00K 64.83K 3.39K 8.94K 81.48K 252.00K n/a n/a
Pretax Income -35.20M -28.21M -26.40M -15.71M -12.26M -20.02M 1.73M 1.19M
Net Income -35.20M -28.21M -26.40M -15.71M -12.26M -20.02M 632.24K 307.30K
Selling & General & Admin 11.90M 5.63M 7.54M 3.00M 2.80M 8.84M 3.61M 4.04M
Research & Development 22.68M 18.10M 17.93M 12.72M 9.54M 9.15M 196.01K n/a
Other Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 34.58M 23.73M 25.47M 15.72M 12.34M 17.99M 3.81M 4.04M
Interest Expense 1.06M 3.60M 876.44K n/a n/a n/a 300.43K 307.45K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 35.74M 23.73M 25.47M 15.72M 12.34M 18.37M 6.98M 7.72M
Income Tax n/a 3.60M 876.44K 8.94K 81.48K n/a 452.78K 201.86K
Shares Outstanding (Basic) 5.06M 3.10M 3.20M 8.15M 8.15M 2.95M 6.12K 6.12K
Shares Outstanding (Diluted) 5.06M 3.10M 3.20M 8.15M 8.15M 2.95M 6.12K 6.12K
EPS (Basic) -6.96 -9.1 -8.25 -1.93 -1.5 -6.79 103.31 50.21
EPS (Diluted) -6.96 -9.1 -8.25 -1.93 -1.5 -6.79 103.31 50.21
EBITDA -32.97M -23.55M -51.92M -15.53M -40.16M -14.34M 62.54K 1.96M
Depreciation & Amortization 1.17M 1.06M 801.00K 628.00K 496.00K 2.00K 460.34K 463.22K

Create Price Alert on ELTX

Your price alert will notify you when the stock price is above 6.35.

Add to Watchlist